Nurexone Biologic Quote - NRX

	Real-time Prices	Level 2
Canadian Securities Exchange

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.71

Bid

0.69

Ask

0.72

Volume

11,334

0.70 Day's Range 0.71

0.26 52 Week Range 1.19

Market Cap

34.257M

Previous Close

0.71

Open

0.70

Last Trade

1000

0.71

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

46,434

Shares Outstanding

48,249,000

Dividend Yield

PE Ratio

-9.42

Earnings Per Share (EPS)

-0.08

Revenue

Net Profit

-3.64M

Sector

Miscellaneous Metal Ores,nec

Industry

Pharmaceutical Preparations

Website

www.nurexone.com

Headquarters

Toronto, Ontario, Can

Founded

2011

Nurexone Biologic Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Exchange with ticker NRX. The last closing price for Nurexone Biologic was $0.71. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0.26 to $ 1.19.

Nurexone Biologic currently has 48,249,000 shares outstanding. The market capitalization of Nurexone Biologic is $34.26 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -9.42.

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

TORONTO and HAIFA, Israel, Oct. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

TORONTO and HAIFA, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

TORONTO and HAIFA, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study

TORONTO and HAIFA, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is pleased to announce compelling...

NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences

TORONTO and HAIFA, Israel, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is pleased to announce that its...

NurExone Biologic Achieves Key Milestone in Support of Robust Exosome Manufacturing Process

Company demonstrates reliable production from multiple biological sourcesThese manufacturing advancements provide NurExone flexibility in optimizing its exosome production method, ensuring...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-2.7397260274	0.73	0.78	0.7	45061	0.73159615	CS
4	0.03	4.41176470588	0.68	0.83	0.59	64274	0.72971804	CS
12	0.15	26.7857142857	0.56	0.83	0.53	46434	0.67125886	CS
26	0.19	36.5384615385	0.52	0.87	0.46	55870	0.68445771	CS
52	0.4	129.032258065	0.31	1.19	0.26	77467	0.73134157	CS
156	-0.09	-11.25	0.8	1.19	0.1	34574	0.69773048	CS
260	-0.09	-11.25	0.8	1.19	0.1	34574	0.69773048	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ENTGEntourage Health Corp	$ 0.015 (200.00%)	2.18M
ACAP.PAtlas One Capital Corporation	$ 0.015 (200.00%)	221.8k
SSESilver Spruce Resources Inc	$ 0.01 (100.00%)	18.01k
XCAP.PExelerate Capital Corp	$ 0.05 (66.67%)	129k
POOLPool Safe Inc	$ 0.04 (60.00%)	158.3k
WWTWater Ways Technologies Inc	$ 0.005 (-50.00%)	52.11k
OSIXOceansix Future Paths Ltd	$ 0.005 (-50.00%)	2.12M
JHCJinhua Capital Corporation	$ 0.005 (-50.00%)	140k
DMDataMetrex AI Limited	$ 0.005 (-50.00%)	130k
MDK.PMDK Acquisition Inc	$ 0.05 (-50.00%)	5k
EGTEguana Technologies Inc	$ 0.01 (0.00%)	2.55M
ENTGEntourage Health Corp	$ 0.015 (200.00%)	2.18M
OSIXOceansix Future Paths Ltd	$ 0.005 (-50.00%)	2.12M
RIORio2 Limited New	$ 0.63 (-4.55%)	2.11M
GBUGabriel Resources Ltd	$ 0.015 (0.00%)	2.02M